Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.32 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.32 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.32 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.30 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.30 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.30 |
| ▸ | CSNK2A3 | Q8NEV1 | 2/20 | 0.30 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4062174 | 0.95 | CSNK2A2 (0.31) | CSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL4062206 | 0.88 | — | — | |
| SCHEMBL4061031 | 0.87 | GNAI3 (0.32) | GNAI3GNAO1GNAI1CSNK2A2CSNK2B | |
| SCHEMBL4059422 | 0.86 | CSNK2A2 (0.33) | GNAI3GNAO1GNAI1CSNK2A2CSNK2B | |
| SCHEMBL4060365 | 0.86 | GNAI3 (0.31) | GNAI3GNAO1GNAI1 | |
| SCHEMBL4069941 | 0.85 | HTR1A (0.33) | GNAI3GNAO1GNAI1HTR1A | |
| SCHEMBL4059963 | 0.82 | CSNK2A2 (0.31) | CSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL128337 | 0.81 | CSNK2A2 (0.34) | CSNK2A2CSNK2BCSNK2A1CSNK2A3PAOX | |
| SCHEMBL4065927 | 0.81 | — | — | |
| SCHEMBL11897269 | 0.80 | CSNK2A2 (0.38) | GNAI3GNAO1GNAI1CSNK2A2CSNK2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7569691-B2 | Protected piperazino group-bearing organoxysilane compound and making method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-08-04 | — | — | US | claimed |
| US-7569691-B2 | Protected piperazino group-bearing organoxysilane compound and making method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-08-04 | — | — | US | disclosed |
| EP-1714968-B1 | Protected piperazino group-bearing organoxysilane compound and making method | SHINETSU CHEMICAL CO (JP) | 2008-07-16 | — | — | EP | disclosed |
| US-20060241294-A1 | Protected piperazino group-bearing organoxysilane compound and making method | SHIN-ETSU CHEMICAL CO., LTD. | 2006-10-26 | — | — | US | disclosed |
| EP-1714968-A1 | Protected piperazino group-bearing organoxysilane compound and making method | Shin-Etsu Chemical Co., Ltd. (JP) | 2006-10-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060241294-A1 | Protected piperazino group-bearing organoxysilane compound and making method | PIEZO1, VCL, VIM | GNAI3 2419/4885GNAO1 646/4885GNAI1 2561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.